Leadership Team

Gregory Skalicky is the Group Chief Executive Officer of Clinigen, having joined the company in July 2026. Greg is an experienced healthcare executive with more than 30 years’ leadership experience across pharmaceutical services, biotechnology and healthcare. He has a strong track record in commercialisation, patient access, global partnerships and leading organisations through periods of growth and change.

Prior to Clinigen, Greg was President of EVERSANA, where he was responsible for accelerating the company’s growth and supporting client commercialisation efforts. He has also held senior leadership roles at Syneos Health and PharmaNet, managing global client relationships and leading large teams across the biopharmaceutical services sector.

Greg holds a Bachelor of Science in Biology from Temple University and a Master of Business Administration from Villanova University.

Kate is SVP, EU, US & ROW at Clinigen, joining the company in 2026. Kate brings 25 years of experience across biotech and pharma, with a background spanning both commercial and R&D leadership roles. 

A strong commercial leader, Kate has deep expertise in CNS conditions, including pain and sleep disorders, alongside experience in osteoporosis, oncology, nephrology and supportive care. She has led cross‑functional teams and delivered commercialisation strategies from preclinical development through to launch across multiple international markets. 

She is an experienced global leader, with a strong track record in driving collaboration across R&D, commercial and partner organisations, and leading transformation initiatives that support growth and expand patient access to medicines.

Dan Piggott is Senior Vice President, Commercial at Clinigen, where he leads the company's global commercial strategy and supports pharmaceutical and biotechnology partners in bringing medicines to patients around the world. With more than 25 years of experience in the life sciences industry, Dan has extensive expertise in product access, specialty medicines, commercialisation, and international market development.

Before joining Clinigen, Dan held senior leadership roles across the pharmaceutical services and biopharmaceutical sectors, including Managing Director of Uniphar Access and Commercial Director for Oncology and Specialty Products at AbbVie. His experience spans managed access programmes, unlicensed medicine supply, commercial launch preparation, and global business growth.

Dan is passionate about improving patient access to innovative therapies and helping pharmaceutical companies navigate complex commercial challenges. He is focused on building strong partnerships, driving commercial excellence, and delivering sustainable growth across the healthcare ecosystem.

Jose brings over a decade of experience in Clinical Services, most recently serving as General Manager - Clinical Trials, at Thermo Fisher Scientific. Earlier in his career, he held engineering leadership roles at Pratt & Whitney and Rexnord Corporation. Jose holds two master’s degrees in engineering and technology from the University of Miami and an MBA from Carnegie Mellon University.

A recognised expert in strategy and business system deployment, Jose is passionate about fostering a culture of continuous improvement. In his new role, one of his key objectives will be to enhance Operational Efficiency and help Clinigen achieve world-class customer service standards.

Tom leads Clinigen's Clinical Trial Sourcing business, overseeing global comparator procurement and clinical supply chains for pharmaceutical and biotech clients in GxP-regulated environments.
Since joining Clinigen in 2018, Tom has progressed from senior finance leadership into full operational and commercial ownership of the business unit. He holds a BA in Business & Managerial Economics from the University of Leeds and is ACMA CGMA qualified.

Suzanne has more than 20 years industry experience and is currently SVP of Managed Access at Clinigen, having joined in January 2013. Since joining Clinigen, Suzanne has been intricately involved in managed access programs; first setting up and running on behalf of clients and, since 2015, leading the growing Program Management function and now Business Unit and with oversight and governance responsibility across the Clinigen MAP portfolio. Prior to joining Clinigen, Suzanne worked client side in large pharma R&D within a range of technical, leadership and project management roles. Suzanne has a PhD in Chemistry. 

Dr Varun Sethi is the SVP for JAPAC region, joining the company in August 2024. Varun is a seasoned healthcare executive with over 22+ years’ experience across pharmaceuticals, medical devices, and diagnostics, and has a deep understanding of the healthcare landscape in Asia Pacific. In the past year, he has led a significant turnaround of the JAPAC business, driving growth and expanding Clinigen’s market footprint.

Prior to Clinigen, Varun held senior leadership roles at DKSH, Fortis Healthcare and Baxter International. He has been a member of the boards of the Pharmaceutical Association of Malaysia (PhAMA) and Singapore Association of Pharmaceutical Companies (SAPI) where he served as Treasurer in both industry associations.

Varun holds a Ph.D. in pharmaceutical sciences from the University of Illinois, Chicago, as well as an Executive Certification in marketing and sales from the Kellogg School of Management, Northwestern University, Chicago.

Carel is a pharmacist by profession and completed his master’s degree in pharmaceutical formulations. His passion for people and assisting healthcare providers and patients to access medicines led him to join Clinigen South Africa in 2009. He started his tenure at the African affiliate overseeing the unlicensed medicine department and established the company as the leading supplier of unlicensed medicine in South Africa. He continued his growth in the organisation and was responsible for business development in the African region. He was appointed as the managing director for the African affiliate in 2018. In his role he oversees the African affiliate which consists of various operational entities including licensed and unlicensed pharmaceutical products and medical devices. He has successfully expanded the organisation and onboarded partnerships with principles across the globe to market and distribute their products in sub-Saharan and East Africa.

Guy Strutton, MCIPD, is the Chief People Officer at Clinigen, where he has played an integral role in shaping the company's human capital strategy for over 20 years. With a deep-rooted understanding of Clinigen's culture and business objectives, Guy is instrumental in driving talent acquisition, development, and retention.

Prior to his current role, Guy held several senior HR positions at Clinigen, including EVP HR and SVP HR. His extensive experience spans various HR functions, from learning and development to global HR business partnering.

Guy holds a Bachelor of Arts in Spanish and Portuguese from the University of Leeds and a Master of Arts in Human Resources Management from Kingston University. 

Merav is a seasoned regulatory affairs professional with over 30 years of experience in the pharmaceutical industry. As Senior Vice President of Pharmacovigilance, Medical Information, and Regulatory Affairs Operations, she leads a global team dedicated to ensuring patient safety and regulatory affairs strategy and submissions.

Trained as a pharmacist with a master’s degree in Biopharmacy from King’s College London, Merav brings a deep understanding of drug development and lifecycle management. Having joined Clinigen in 2014, her expertise is instrumental in guiding Clinigen’s global projects through complex regulatory landscapes.

Merav is passionate about building high-performing teams and fostering a culture of excellence. Under her leadership, the Clinigen team delivers exceptional pharmacovigilance, medical information, and regulatory support to clients worldwide.